These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3635664)

  • 21. [Pathogenetic factors of Alzheimer disease].
    Bauer J; Hüll M; Berger M
    Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
    Price DL; Cork LC; Struble RG; Whitehouse PJ; Kitt CA; Walker LC
    Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283
    [No Abstract]   [Full Text] [Related]  

  • 23. Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Gauthier S; Nair NP
    Can J Physiol Pharmacol; 1986 Mar; 64(3):318-24. PubMed ID: 3708439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic structures and neuropathologic alterations in the olfactory bulb of Alzheimer's disease brain samples.
    Kovacs I; Torok I; Zombori J; Kasa P
    Brain Res; 1998 Apr; 789(1):167-70. PubMed ID: 9602111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease.
    Holtzman DM; Li YW; Gage FH; DeArmond SJ; Epstein CJ; McKinley MP; Mobley WC
    Prog Clin Biol Res; 1991; 373():189-202. PubMed ID: 1838184
    [No Abstract]   [Full Text] [Related]  

  • 26. Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation.
    Masliah E; Terry R; Buzsáki G
    Brain Res; 1989 Jul; 493(2):240-6. PubMed ID: 2765898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrahypophyseal distribution of alpha-melanocyte stimulating hormone (alpha-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer-type dementia patients.
    Arai H; Moroji T; Kosaka K; Iizuka R
    Brain Res; 1986 Jul; 377(2):305-10. PubMed ID: 3524751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?
    Mesulam M
    Learn Mem; 2004; 11(1):43-9. PubMed ID: 14747516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance and function of the melanocyte-stimulating hormone in malignant melanoma. Importance of MSH].
    Beyer C; Kaufmann K; Wehner F
    Dermatol Monatsschr; 1990; 176(10):589-96. PubMed ID: 1964135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.
    Sawyer TK; Hruby VJ; Darman PS; Hadley ME
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1751-5. PubMed ID: 6281785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease.
    Hefti F; Will B
    J Neural Transm Suppl; 1987; 24():309-15. PubMed ID: 2824691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease.
    Woolf NJ; Jacobs RW; Butcher LL
    Neurosci Lett; 1989 Jan; 96(3):277-82. PubMed ID: 2717053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cholinergic hypothesis--ten years on.
    Perry EK
    Br Med Bull; 1986 Jan; 42(1):63-9. PubMed ID: 3513895
    [No Abstract]   [Full Text] [Related]  

  • 36. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
    Pinto T; Lanctôt KL; Herrmann N
    Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Oct; 625(1):125-38. PubMed ID: 8242391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine regulation and central dopamine (DA) systems in physical and psychological stress.
    Monnet F; Lichtensteiger W
    J Physiol (Paris); 1980 Jul; 76(3):273-5. PubMed ID: 7191005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senile dementia of Alzheimer's type--current concepts and prospects.
    Biesold D
    Z Psychol Z Angew Psychol; 1986; 194(3):311-29. PubMed ID: 2881405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.